Atlas Trials

Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues

Clinical trial NCT01911156 · UNKNOWN

Trial details

NCT number
NCT01911156
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2013-07-01
Primary completion
2016-01-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.